New Autism Therapy Shows Surprising Benefits Even in Adult Mice Research has challenged the notion that neurological disorders are a product of early developmental failures by investigating autism therapy.
A recent study on mice has demonstrated remarkable benefits from a new treatment targeting a specific glycine transporter, raising hopes for more effective interventions in adults with autism.
The breakthrough centers around a receptor known as Slc6a20a/SLC6A20, which plays a crucial role in communication between brain cells.